Latest News about VRTX
Recent news which mentions VRTX
   CRISPR Therapeutics (CRSP) Stock Jumps as U.K. Authorizes Gene Therapy
   
  
  
  November 16, 2023
  From InvestorPlace
 
   UK Approves First Crispr Gene Edited Therapy For Sickle Cell Disease, Beta Thalassemia
   
  
  
  November 16, 2023
  From Benzinga
 
   10 Health Care Stocks Whale Activity In Today's Session
   
  
  
  November 15, 2023
  From Benzinga
 
   How Is The Market Feeling About Vertex Pharmaceuticals?
   
  November 14, 2023
  Tickers 
   VRTX
  
  
  From Benzinga
 
   Right Now Could Be a Once-in-a-Generation Opportunity to Buy These Cathie Wood Stocks
   
  
  
  November 14, 2023
  From Motley Fool
 
   2 Stocks to Buy Hand Over Fist as the S&P 500 Rockets Higher
   
  
  
  November 14, 2023
  From Motley Fool
 
   3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
   
  
  
  November 12, 2023
  From Motley Fool
 
   1 No-Brainer Stock to Buy and Hold for 10 Years
   
  
  
  November 11, 2023
  From Motley Fool
 
   3 Growth Stocks to Buy Right Now Without Any Hesitation
   
  
  
  November 11, 2023
  From Motley Fool
 
   4 First-in-Their-Class Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
   
  
  
  November 11, 2023
  From Motley Fool
 
   3 Biotech Stocks That Are Betting on the Future of Gene Editing
   
  
  
  November 09, 2023
  From InvestorPlace
 
   This Program for a Common Problem May Be Vertex Pharmaceuticals' Ticket to a New Wave of Billion-Dollar Revenues
   
  
  
  November 09, 2023
  From Motley Fool
 
   4 Reasons to Worry About Vertex Pharmaceuticals -- Debunked
   
  November 08, 2023
  Tickers 
   VRTX
  
  
  From Motley Fool
 
   What 10 Analyst Ratings Have To Say About Vertex Pharmaceuticals
   
  November 07, 2023
  Tickers 
   VRTX
  
  
  From Benzinga
 
   S&P 500, Nasdaq Set To Break 6-Day Rally Today? Traders Await Fed Cues, Analyst Says Seasonal Rally Has Started With Gusto
   
  
  
  November 07, 2023
  From Benzinga
 
   Vertex Pharmaceuticals (VRTX) Q3 2023 Earnings Call Transcript
   
  November 07, 2023
  Tickers 
   VRTX
  
  
  From Motley Fool
 
   Earnings Scheduled For November 6, 2023
   
  
  
  November 06, 2023
  From Benzinga
 
   US Stocks Set To Extend 5-Day Winning Streak Today? Traders Anxiously Watch Fed Speech, Climbing Bond Yields
   
  
  
  November 06, 2023
  From Benzinga
 
   S&P 500 futures show stocks extending latest rally
   
  
  
  November 06, 2023
  From MarketWatch
 
   7 Tech Stocks to Buy and Hold for the Next 25 Years
   
  
  
  November 05, 2023
  From InvestorPlace
 
   Fed Holds Rates Steady, Powell's Cautious Stance Soothes Investors, Labor Market Softens: The Week In The Markets
   
  
  
  November 03, 2023
  From Benzinga
 
   Here's What Investors Need to Know About Vertex Pharmaceuticals and CRISPR Therapeutics' Big Day at the FDA
   
  
  
  November 03, 2023
  From Motley Fool
 
   One Month Ahead of its Most Crucial Moment Ever, Should You Buy CRISPR Therapeutics?
   
  
  
  November 02, 2023
  From Motley Fool
 
   Crispr Therapeutics’ stock soars as FDA-panel meeting raises hopes sickle-cell-disease drug will be approved
   
  
  
  November 01, 2023
  From MarketWatch
 
   Here's How Much $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today
   
  November 01, 2023
  Tickers 
   VRTX
  
  
  From Benzinga
 
   Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient
   
  
  
  October 30, 2023
  From Motley Fool
 From Motley Fool
 From InvestorPlace
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

